What is the catalog number for MBP Peptide - middle region (AAP56223)?

The catalog number for MBP Peptide - middle region (AAP56223) is AAP56223-100UG.

What sizes are available for MBP Peptide - middle region (AAP56223)?

MBP Peptide - middle region (AAP56223) is available in the following size(s): 100 µg.

Is MBP Peptide - middle region (AAP56223) in stock?

MBP Peptide - middle region (AAP56223) is currently made to order / not held in immediate stock. Contact us for lead time.

Do you offer custom or private-label production of this type of product?

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

What is the immunogen used to generate this antibody?

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

What is the recommended positive control for this assay?

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

MBP Peptide - middle region (AAP56223)

Product Specifications

Gene Aliases

MGC99675

Gene ID

4155

Accession Number

NP_001020272

Target

This is a synthetic peptide designed for use in combination with anti-MBP antibody (Catalog #: ARP56223_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

Partner Proteins

MAPK1, PRKCA, PRKCD, PRKCI, PRKCZ, ROCK1, ROCK2, APTX, ATN1, ATXN1, BMP2K, CDK12, CLK1, CTDSP1, DYRK1B, EFHA1, HLA-DRA, IRAK1, MAG, MAPK1, MAPK11, MAPK13, MAPK14, MAPK15, MAPK3, MAPKAPK5, MELK, MKNK1, MMP7, MST4, NEK9, PAK1, PLP1, PRKACA, PRKCA, PRKCD, PRKCI, PRKCZ, PRMT1, PRMT5, RAN, RPS6KA5, RTN4, SRPK1, STK16, STK39, STK4, TLK1, TLK2, TRAF6, TRPM7, HLA-DRA, PLP1, PRMT5, STK39, TRPM7

Type

Blocking Peptide

Applications

Assay Protocol

Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol

Format

Lyophilized powder

Reconstitution

Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.